Please wait
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
January 27, 2026
Accession Number:
0001213900-26-007469
Submission Type:
POS AM
CIK:
0001841330
Company Name:
Pasithea Therapeutics Corp.
File Number:
333-271010